Cell-surface glycoprotein having a role in immunoadhesion. Mediates in the adhesion of blood neutrophils in cytokine-activated endothelium through interaction with SELPLG/PSGL1. May have a role in capillary morphogenesis
Interacts with SELPLG/PSGL1 and PODXL2 through the sialyl Lewis X epitope. SELPLG sulfation appears not to be required for this interaction
Click a pathway to open the interactive Reactome viewer.
Genes with an experimentally identified or computationally predicted synthetic-lethal relationship to SELENOM, aggregated across our SSL data sources. Click any partner node to view that gene’s page.
Nodes and edges are coloured by the SSL data source. Partners appearing in more than one source are shown in grey.
Total Trials Found: 1
| NCT ID | Condition | Brief Title | Phase | Status |
|---|---|---|---|---|
| NCT06900361 | Asthma Self Management | Use of Mobile Phone Application for Asthma Sele Management | N/A | COMPLETED |
| NCT06962462 | Erectile Dysfunction Associated With Type 2 Diabetes Mellitus | Daily Tadalafil in Diabetic ED Patients | NA | NOT_YET_RECRUITING |
| NCT05312788 | Cardiovascular Diseases, Kidney Diseases | Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health | NA | COMPLETED |
| NCT00012454 | Cerebrovascular Accident, Transient Ischemic Attack | E-Selectin Nasal Spray to Prevent Stroke Recurrence | PHASE2 | TERMINATED |
| NCT06286098 | Hemodialysis Complication, Pediatric Kidney Disease, Cardiovascular Complication | Alpha Lipoic Acid in Pediatrics on Hemodialysis | PHASE3 | ENROLLING_BY_INVITATION |
| NCT00457171 | Ulcerative Colitis | GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis | PHASE1 | TERMINATED |
| NCT02306291 | Leukemia, Myeloid, Acute | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML | PHASE1, PHASE2 | COMPLETED |
| NCT05146739 | Acute Myeloid Leukemia Post Cytotoxic Therapy, Myelodysplastic Syndrome Post Cytotoxic Therapy, Myeloid Leukemia Associated With Down Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia, Refractory Mixed Phenotype Acute Leukemia, Refractory Myelodysplastic Syndrome | Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane | PHASE1 | ACTIVE_NOT_RECRUITING |
| NCT00069069 | Ischemic Attack, Transient, Transient | E-Selectin Nasal Instillation to Prevent Secondary Stroke | PHASE1 | WITHDRAWN |